These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Treatment of lung cancer]. Tomita M Gan No Rinsho; 1989 Jan; Spec No():128-37. PubMed ID: 2536852 [No Abstract] [Full Text] [Related]
4. The use of combination immunotherapies as front-line therapy for non-small-cell lung cancer. Santana-Davila R; Chow LQ Future Oncol; 2018 Feb; 14(3):191-194. PubMed ID: 29334785 [No Abstract] [Full Text] [Related]
5. Chemo-immunotherapy: The Beginning of a New Era in Lung Cancer. Uprety D Clin Lung Cancer; 2019 Mar; 20(2):63-65. PubMed ID: 30545572 [No Abstract] [Full Text] [Related]
6. Treatment of N2 non-small cell lung cancer (NSCLC). Klastersky J; Feld R; Kleisbauer JP; Rocmans P Chest; 1989 Jul; 96(1 Suppl):83S-85S. PubMed ID: 2544376 [No Abstract] [Full Text] [Related]
7. [Immunotherapy of metastatic non-small cell lung cancer from first line to resistance and its management]. Basse C; Swalduz A; Levra MG; Girard N; Remon J; Moro-Sibilot D Bull Cancer; 2020; 107(7-8):779-791. PubMed ID: 32532420 [TBL] [Abstract][Full Text] [Related]
9. [Neoadjuvant treatment for early stages of non-small-cell lung carcinoma (NSCLC)]. Moro D Rev Pneumol Clin; 2001 Nov; 57(5 Pt 2):S22-4. PubMed ID: 11924237 [No Abstract] [Full Text] [Related]
10. Current status of and future strategies for multimodality treatment of unresectable stage III nonsmall cell lung cancer. Huber RM; Reck M; Thomas M Eur Respir J; 2013 Oct; 42(4):1119-33. PubMed ID: 23429914 [TBL] [Abstract][Full Text] [Related]
11. [Therapeutic management of non-small-cell lung carcinoma (NSCLC) of stage III A]. Mornex F Rev Pneumol Clin; 2001 Nov; 57(5 Pt 2):S29-32. PubMed ID: 11924239 [No Abstract] [Full Text] [Related]
13. Chemotherapy of non-small cell lung cancer. Williams CJ Br J Cancer; 1989 Jul; 60(1):9-11. PubMed ID: 2553089 [No Abstract] [Full Text] [Related]
14. Chemotherapy in lung cancer. Price CG; Slevin ML Postgrad Med J; 1989 May; 65(763):291-8. PubMed ID: 2558370 [No Abstract] [Full Text] [Related]
15. Therapeutic outcomes of combining cryotherapy, chemotherapy and DC-CIK immunotherapy in the treatment of metastatic non-small cell lung cancer. Yuanying Y; Lizhi N; Feng M; Xiaohua W; Jianying Z; Fei Y; Feng J; Lihua H; Jibing C; Jialiang L; Kecheng X Cryobiology; 2013 Oct; 67(2):235-40. PubMed ID: 23948179 [TBL] [Abstract][Full Text] [Related]
16. Neoadjuvant Therapy in Non-Small Cell Lung Cancer. Zheng Y; Jaklitsch MT; Bueno R Surg Oncol Clin N Am; 2016 Jul; 25(3):567-84. PubMed ID: 27261916 [TBL] [Abstract][Full Text] [Related]
17. Chemoradiotherapy of locally advanced nonsmall cell lung cancer: state of the art and perspectives. Antoni D; Mornex F Curr Opin Oncol; 2016 Mar; 28(2):104-9. PubMed ID: 26848885 [TBL] [Abstract][Full Text] [Related]
18. Controversies in the nonsurgical treatment of stage III non-small cell lung cancer. Hazuka MB; Bunn PA Am Rev Respir Dis; 1992 Apr; 145(4 Pt 1):967-77. PubMed ID: 1313216 [No Abstract] [Full Text] [Related]
19. [Adjuvant treatment for early stages of non-small-cell lung carcinoma (NSCLC)]. Papadakis E Rev Pneumol Clin; 2001 Nov; 57(5 Pt 2):S25-8. PubMed ID: 11924238 [No Abstract] [Full Text] [Related]